GCTK Stock Summary and Trading Ideas (Glucotrack | NASDAQ:GCTK)

GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.

What symbol and exchange does Glucotrack shares trade?

Glucotrack trades on the NASDAQ stock market under the symbol GCTK.

What is Glucotrack stock price doing today?

As of December 26, 2025, GCTK stock price declined to $4.20 with 12,156 million shares trading.

What is Glucotrack's Beta?

GCTK has a beta of 2.66, meaning it tends to be more sensitive to market movements. GCTK has a correlation of 0.07 to the broad based SPY ETF.

How much is Glucotrack worth?

GCTK has a market cap of $3.82 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Glucotrack traded in the last 3 year period?

In the last 3 years, GCTK traded as high as $22,500.00 and as low as $4.17.

Is Glucotrack (GCTK) a good investment?

GCTK has underperformed the market in the last year with a price return of -98.6% while the SPY ETF gained +16.0%. GCTK has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -27.5% and -31.0%, respectively, while the SPY returned +4.7% and +0.7%, respectively.

What are the support and resistance levels for Glucotrack (GCTK)?

GCTK support price is $4.10 and resistance is $4.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GCTK shares will trade within this expected range on the day.